Enanta Pharmaceuticals Inc (ENTA)
11.41
+0.22
(+1.97%)
USD |
NASDAQ |
Oct 04, 16:00
11.42
+0.02
(+0.13%)
After-Hours: 20:00
Enanta Pharmaceuticals Shareholders Equity (Annual): 216.74M for Sept. 30, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 216.74M |
| September 30, 2022 | 321.33M |
| September 30, 2021 | 399.43M |
| September 30, 2020 | 455.58M |
| September 30, 2019 | 462.49M |
| September 30, 2018 | 393.68M |
| September 30, 2017 | 301.68M |
| Date | Value |
|---|---|
| September 30, 2016 | 269.94M |
| September 30, 2015 | 236.16M |
| September 30, 2014 | 148.65M |
| September 30, 2013 | 110.47M |
| September 30, 2012 | 43.93M |
| September 30, 2011 | 21.95M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
216.74M
Minimum
2023
455.58M
Maximum
2020
348.27M
Average
360.38M
Median
Shareholders Equity (Annual) Benchmarks
| Ardelyx Inc | 166.82M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |